Technology area: Biotechnology & Pharmaceuticals
49 pending office actions • 37 art units • 49 examiners • 0 of 49 (0%) have an AI response strategy ready • 68 patents granted in the last 365 days
Bayer Aktiengesellschaft has 50 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 50 examiners and 38 art units, so examiner coverage is fully distributed while several matters share art-unit environments. This structure calls for centralized docket control with technical coordination across units.
CAHILL, JESSICA MARIE is the busiest examiner, with 1 pending action. No examiner accounts for more than that amount in the supplied data, which limits the value of concentrating portfolio strategy around any one examiner. Counsel should instead identify recurring issues by art unit and technology subgroup.
Based on the USPTO statutory response window for each pending office action. 13 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 13 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (4%) |
| §101 + other | 8 (16%) |
| §103 only | 13 (27%) |
| §102 only | 2 (4%) |
| §112 only | 4 (8%) |
| Double-patenting only | 1 (2%) |
| Double-patenting + other | 7 (14%) |
| Multi-statute (no §101) | 11 (22%) |
| No statute on record | 1 (2%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CAHILL, JESSICA MARIE | 1 | 78.6% | +22.7% |
| LEE, CHEE-CHONG | 1 | 64.3% | +52.5% |
| WANG, CLAIRE X | 1 | 71.3% | +7.6% |
| CRADDOCK, ROBERT J | 1 | 83.9% | +14.4% |
| ZHANG, WAYNE | 1 | 59.3% | +43.3% |
| VILLECCO, JOHN M | 1 | 64.5% | +9.5% |
| CHANG, FANG-CHI | 1 | 70.5% | -29.8% |
| JOHNSON, CHRISTOPHER LINDSAY | 1 | 48.6% | +78.3% |
| SZNAIDMAN, MARCOS L | 1 | 37.4% | +16.1% |
| NGUYEN, LEON VIET Q | 1 | 85.2% | +10.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18982684 | Generating synthetic images | CRADDOCK, ROBERT J | — |
| 18859363 | MULTIPLE-INSTANCE LEARNING BASED ON REGIONAL EMBEDDINGS | NGUYEN, LEON VIET Q | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18666545 | CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS | KAUFMAN, CLAIRE M | 36d overdue |
| 18251509 | AGROCHEMICAL COMPOSITION WITH IMPROVED DRIFT, SPREADING AND UPTAKE PROPERTIES | ZHANG SPIERING, DONGXIU | 23d overdue |
| 18264068 | SUBSTITUTED (2-HETEROARYLOXYPHENYL)SULFONATES, SALTS THEREOF AND THEIR USE AS HERBICIDAL AGENTS | RHOADES, DEREK JAMES | 26d |
| 17860684 | METHOD FOR CREATING A RENAL INJURY MODEL TO SCREEN MOLECULES FOR THE TREATMENT OF RENAL INJURY | BAEK, JONGHWAN NMN | 79d |
| 19164766 | MODIFIED VALVE FOR USE IN A FLOW PATH | CAHILL, JESSICA MARIE | — |
| 19102967 | PROSTATE CANCER LOCAL STAGING | WANG, CLAIRE X | — |
| 18873638 | IDENTIFICATION AND CHARACTERIZATION OF PANCREATIC CYSTIC LESIONS | VILLECCO, JOHN M | — |
| 18870887 | DEVICE FOR ASSISTING WITH THE CREATION OF IMAGE RECORDS, USE OF THE DEVICE AND METHOD FOR CREATING AN IMAGE RECORD | CHANG, FANG-CHI | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19164766 | MODIFIED VALVE FOR USE IN A FLOW PATH | CAHILL, JESSICA MARIE | — |
| 19114119 | ACCURATE APPLICATION OF LIQUIDS IN A FIELD FOR CROP PLANTS | LEE, CHEE-CHONG | — |
| 18982684 | Generating synthetic images | CRADDOCK, ROBERT J | — |
| 18977516 | GENERATING SYNTHETIC REPRESENTATIONS | ZHANG, WAYNE | — |
| 18862344 | USE OF (5S)-3-[3-(3-CHLORO-2-FLUOROPHENOXY)-6-METHYLPYRIDAZIN-4-YL]-5-(2-CHLORO-4-METHYLBENZYL)-5,6-DIHYDRO-4H-1,2,4-OXADIAZINE FOR CONTROLLING UNWANTED MICROORGANISMS | JOHNSON, CHRISTOPHER LINDSAY | — |
| 18925716 | SUBSTITUTED OXOPYRIDINE DERIVATIVES FOR THE TREATMENT AND/OR PROPHYLAXIS OF THROMBOTIC OR THROMBOEMBOLIC DISORDERS AND/OR THROMBOTIC OR THROMBOEMBOLIC COMPLICATIONS | SZNAIDMAN, MARCOS L | — |
| 18859363 | MULTIPLE-INSTANCE LEARNING BASED ON REGIONAL EMBEDDINGS | NGUYEN, LEON VIET Q | — |
| Art Unit | Apps |
|---|---|
| 1626 | 3 |
| 1612 | 3 |
| 1691 | 2 |
| 1674 | 2 |
| 1653 | 2 |
| 1624 | 2 |
| 1628 | 2 |
| 1692 | 2 |
| 1616 | 2 |
| 3753 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19164766 | MODIFIED VALVE FOR USE IN A FLOW PATH | CAHILL, JESSICA MARIE | 3753 | §102§103 | Non-Final OA | — | Pending | Sep 12, 2025 |
| 19114119 | ACCURATE APPLICATION OF LIQUIDS IN A FIELD FOR CROP PLANTS | LEE, CHEE-CHONG | 3752 | §103 | Non-Final OA | — | Pending | Mar 21, 2025 |
| 19102967 | PROSTATE CANCER LOCAL STAGING | WANG, CLAIRE X | 1774 | §102§103 | Non-Final OA | — | Pending | Feb 11, 2025 |
| 18982684 | Generating synthetic images | CRADDOCK, ROBERT J | 2618 | §102 | Non-Final OA | — | Pending | Dec 16, 2024 |
| 18977516 | GENERATING SYNTHETIC REPRESENTATIONS | ZHANG, WAYNE | 2672 | §112 | Non-Final OA | — | Pending | Dec 11, 2024 |
| 18873638 | IDENTIFICATION AND CHARACTERIZATION OF PANCREATIC CYSTIC LESIONS | VILLECCO, JOHN M | 2661 | §101§102 | Non-Final OA | — | Pending | Dec 10, 2024 |
| 18870887 | DEVICE FOR ASSISTING WITH THE CREATION OF IMAGE RECORDS, USE OF THE DEVICE AND METHOD FOR CREATING AN IMAGE RECORD | CHANG, FANG-CHI | 2852 | §102§103 | Non-Final OA | — | Pending | Dec 02, 2024 |
| 18862344 | USE OF (5S)-3-[3-(3-CHLORO-2-FLUOROPHENOXY)-6-METHYLPYRIDAZIN-4-YL]-5-(2-CHLORO-4-METHYLBENZYL)-5,6-DIHYDRO-4H-1,2,4-OXADIAZINE FOR CONTROLLING UNWANTED MICROORGANISMS | JOHNSON, CHRISTOPHER LINDSAY | 1691 | §101§102§112DP | Non-Final OA | — | Pending | Nov 01, 2024 |
| 18925716 | SUBSTITUTED OXOPYRIDINE DERIVATIVES FOR THE TREATMENT AND/OR PROPHYLAXIS OF THROMBOTIC OR THROMBOEMBOLIC DISORDERS AND/OR THROMBOTIC OR THROMBOEMBOLIC COMPLICATIONS | SZNAIDMAN, MARCOS L | — | §101§102§112Other | Non-Final OA | — | Pending | Oct 24, 2024 |
| 18859363 | MULTIPLE-INSTANCE LEARNING BASED ON REGIONAL EMBEDDINGS | NGUYEN, LEON VIET Q | 2663 | §103 | Non-Final OA | — | Pending | Oct 23, 2024 |
| 18893545 | SUBSTITUTED PYRAZOLO PIPERIDINE CARBOXYLIC ACIDS | ROBINSON, MIKHAIL O'DONNEL | 1627 | §101§112DP | Non-Final OA | — | Pending | Sep 23, 2024 |
| 18841816 | CALIBRATION OF MACHINING TOOLS FOR A PRECISION AGRICULTURE | COLLINS, GARY | 2115 | §101 | Non-Final OA | — | Pending | Aug 27, 2024 |
| 18776651 | DETECTION OF ARTIFACTS IN SYNTHETIC IMAGES | VU, KHOA | 2611 | §103 | Final Rejection | 14d | Pending | Jul 18, 2024 |
| 18724284 | SEED TREATMENT METHODS FOR INCREASING YIELD IN CROP PLANTS | MELLER, MICHAEL V | 1655 | §103 | Non-Final OA | — | Pending | Jun 26, 2024 |
| 18722233 | COMBINATION OF AN A2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONIST WITH A NOREPINEPHRINE REUPTAKE INHIBITOR FOR THE TREATMENT OF SLEEP APNEA | RAHMANI, NILOOFAR | 1691 | §102 | Non-Final OA | — | Pending | Jun 20, 2024 |
| 18719447 | USE OF ISOXAZOLINECARBOXAMIDE FOR SPROUT INHIBITION | ROSSI, JULIA ANNE LORRAIN | 1615 | §103§112 | Non-Final OA | — | Pending | Jun 13, 2024 |
| 18716645 | METHOD FOR PRODUCING ISOXAZOLINECARBOXYLIC ACID DERIVATIVES | FETTEROLF, BRANDON J | 1626 | §103§112 | Non-Final OA | — | Pending | Jun 05, 2024 |
| 18678323 | GENERATION OF ARTIFICIAL CONTRAST-ENHANCED RADIOLOGICAL IMAGES | RHIM, WOO CHUL | 2676 | §101§103 | Non-Final OA | — | Pending | May 30, 2024 |
| 18666545 | CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS | KAUFMAN, CLAIRE M | 1674 | §103§112 | Final Rejection | 36d overdue | Pending | May 16, 2024 |
| 18656211 | GENERATING SYNTHETIC TRAINING DATA | CZEKAJ, DAVID J | 2487 | — | Non-Final OA | — | Pending | May 06, 2024 |
| 18652720 | CELL DISSOCIATION DEVICE AND METHOD | BARRON, SEAN C | 1653 | §103§112 | Non-Final OA | — | Pending | May 01, 2024 |
| 18626788 | PROCESS FOR PREPARING SUBSTITUTED CYCLOHEXANE AMINO ACID ESTERS AND SPIROKETAL-SUBSTITUTED CYCLIC KETO-ENOLS | COUGHLIN, MATTHEW P | 1626 | §103§112DP | Non-Final OA | 59d overdue | Pending | Apr 04, 2024 |
| 18688014 | SUBSTITUTED S-ALANINATE DERIVATIVES | GONZALEZ, LUISALBERTO | 1624 | §101§112DP | Non-Final OA | — | Pending | Feb 29, 2024 |
| 18685717 | NOVEL PYRAZINYL-TRIAZOLE COMPOUNDS AS PESTICIDES | RODRIGUEZ, RAYNA B | 1628 | §112 | Non-Final OA | — | Pending | Feb 22, 2024 |
| 18682551 | ACTIVE COMPOUND COMBINATIONS AND FUNGICIDE COMPOSITIONS COMPRISING THOSE | CHANG, KYUNG SOOK | 1628 | §103 | Non-Final OA | — | Pending | Feb 09, 2024 |
| 18294532 | SIMILARITY RETRIEVAL | KABIR, SAMIYAH | 2126 | §101§103Other | Non-Final OA | — | Pending | Feb 01, 2024 |
| 18291287 | METHOD FOR PREPARING (2,2,2-TRIFLUOROETHYL)SULFANYLANILINE DERIVATIVES | CUTLIFF, YATE KAI RENE | 1692 | §103 | Non-Final OA | — | Pending | Jan 23, 2024 |
| 18580498 | Method For Spot-Treatment Application Against Weeds | MEYERS, ELIZABETH ANNE | 1617 | §103§112DP | Non-Final OA | — | Pending | Jan 18, 2024 |
| 18573793 | FEDERATED REPRESENTATION LEARNING WITH CONSISTENCY REGULARIZATION | STARKS, WILBERT L | 2122 | §101 | Non-Final OA | — | Pending | Dec 22, 2023 |
| 18390207 | HERBICIDALLY ACTIVE BICYCLIC BENZAMIDES | HIRT, ERIN E | 1616 | §103§112DP | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18570478 | N-(1,3,4-1-OXADIAZOL-2-YL)PHENYLCARBOXAMIDES AS HERBICIDES | ABBAS, ABDULRAHMAN MUSTAFA | 1612 | §103 | Non-Final OA | — | Pending | Dec 14, 2023 |
| 18570473 | CHIRAL 3-SULFINYL BENZOIC ACIDS | MARTIN, KEVIN STEPHEN | 1624 | §103 | Final Rejection | — | Pending | Dec 14, 2023 |
| 18549497 | CHIRAL N-(1,3,4-OXADIAZOLE-2-YL)PHENYL CARBOXYLIC ACID AMIDES AND THEIR USE AS HERBICIDES | TIEN, LUCY MINYU | 1612 | §103Other | Final Rejection | 70d | Pending | Sep 07, 2023 |
| 18549281 | CRYSTALLINE FORMS OF (4S)-24-CHLORO-4-ETHYL-73-FLUORO-35-METHOXY-32,5-DIOXO-14-(TRIFLUORO-METHYL)-32H-6-AZA-3(4,1)-PYRIDINA-1(1)-[1,2,3]TRIAZOLA-2(1,2),7(1)-DIBENZENAHEPTAPHANE-74-CARBOXAMIDE | CHEN, PO-CHIH | 1621 | §112 | Final Rejection | 2d overdue | Pending | Sep 06, 2023 |
| 18278724 | METHOD FOR ISOLATING AN AQUEOUS HYDROCHLORIC ACID SOLUTION OF FECL3 FROM AN AQUEOUS MULTI-COMPONENT SYSTEM | SIMKINS, SLONE ELIZABETH | 1735 | §103 | Final Rejection | 4d overdue | Pending | Aug 24, 2023 |
| 18277576 | INHIBITORS OF IL-11 OR IL-11Ra FOR USE IN THE TREATMENT OF ABNORMAL UTERINE BLEEDING | ABBAS, SYED JARAR | 1674 | §102§103§112 | Non-Final OA | — | Pending | Aug 16, 2023 |
| 18450086 | TRIPLE STABILIZER SYSTEM | MITCHELL, EDWIN COLEMAN | 1619 | §103DP | Final Rejection | 4d overdue | Pending | Aug 15, 2023 |
| 18264068 | SUBSTITUTED (2-HETEROARYLOXYPHENYL)SULFONATES, SALTS THEREOF AND THEIR USE AS HERBICIDAL AGENTS | RHOADES, DEREK JAMES | 1692 | §102§103 | Non-Final OA | 26d | Pending | Aug 02, 2023 |
| 18258013 | USE OF DHODH INHIBITOR FOR CONTROLLING RESISTANT PHYTOPATHOGENIC FUNGI IN CROPS | IVANOVA, SVETLANA M | 1626 | §103 | Non-Final OA | 76d | Pending | Jun 16, 2023 |
| 18251816 | AGROCHEMICAL COMPOSITION WITH IMPROVED DRIFT, SPREADING AND RAINFASTNESS PROPERTIES | MAEWALL, SNIGDHA | 1612 | §103§112DP | Final Rejection | — | Pending | May 04, 2023 |
| 18251509 | AGROCHEMICAL COMPOSITION WITH IMPROVED DRIFT, SPREADING AND UPTAKE PROPERTIES | ZHANG SPIERING, DONGXIU | 1616 | §103§112Other | Non-Final OA | 23d overdue | Pending | May 02, 2023 |
| 18251413 | LOW DRIFT, RAINFASTNESS, HIGH UPTAKE AND ULV TANK MIX ADJUVANT FORMULATION | JANOSKO, CHASITY PAIGE | 1613 | §103 | Final Rejection | — | Pending | May 02, 2023 |
| 18032067 | SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER | HIRAKIS, SOPHIA P | 1623 | §103DP | Final Rejection | 30d overdue | Pending | Apr 14, 2023 |
| 18182093 | ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS | HUYNH, PHUONG N | 1641 | §112DP | Final Rejection | 120d overdue | Pending | Mar 10, 2023 |
| 18023318 | DOSING SCHEDULE FOR A METHOD OF TREATMENT WITH DHODH INHIBITORS | LADD, CAROLYN LOUISE | 1622 | §112 | Final Rejection | — | Pending | Feb 24, 2023 |
| 17860684 | METHOD FOR CREATING A RENAL INJURY MODEL TO SCREEN MOLECULES FOR THE TREATMENT OF RENAL INJURY | BAEK, JONGHWAN NMN | 1618 | §103§112 | Non-Final OA | 79d | Pending | Jul 08, 2022 |
| 17762779 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | ENGLISH, CONNOR KENNEDY | 1625 | DP | Non-Final OA | — | Pending | Mar 23, 2022 |
| 17633568 | PREDICTION OF RESIDUES OF PLANT PROTECTION AGENTS IN HARVESTED PRODUCTS | SIMS, JASON M | 3791 | §101§112 | Non-Final OA | — | Pending | Feb 07, 2022 |
| 17057939 | AGROCHEMICAL FORMULATIONS CONTAINING A POLYMERIC CRYSTAL GROWTH INHIBITOR | BOWERS, ERIN M | 1653 | §103 | Non-Final OA | — | Pending | Nov 23, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBayer Aktiengesellschaft has 49 pending office actions as of October 2026, spread across 37 art units and 49 examiners.
Jessica Marie Cahill has the most, with 1 of Bayer Aktiengesellschaft's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
